| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Dec 9, 2025 | Adverum Biotechnologies, Inc. | 10% Owner | Sell | 15.0 | -4,288,949 | -100.00% | ✗ | $15.3M |
| Sep 23, 2021 | Sep 28, 2021 | Viridian Therapeutics, Inc.\DE | 10% Owner | Buy | 100.0 | +200,000 | 15.32% | ✗ | $2.2M |